Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in India
Status:
Recruiting
Trial end date:
2022-03-18
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of flexible doses of
vortioxetine (5 - 20 mg/day) over a period of 12 weeks in patients with depression in India